Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Episode 31: Effect of the Hydrus Microstent

Steven Vold, MD, chief medical editor of Glaucoma Today, speaks with Thomas Samuelson, MD, of Minnesota Eye Consultants regarding the Hydrus Microstent (Ivantis). Dr. Samuelson provides an overview of the data from the Hydrus II study—a prospective, randomized, multicenter comparison of cataract surgery alone versus in combination with the implantation of the Hydrus Microstent. Drs. Vold and Samuelson discuss the 2-year results of this European trial and the importance of a medication washout in such research.


22 / 52 Series: Glaucoma Today Journal Club


More Videos in this Series